Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Recommended
Top holiday events in the Triangle: Tree lightings, parades, and festive markets await
Recommended
Vote now: 2024 WRAL Voters' Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Lonza Group Ag ADR
(OP:
LZAGY
)
57.53
-4.74 (-7.61%)
Streaming Delayed Price
Updated: 3:51 PM EST, Nov 15, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Lonza Group Ag ADR
Swiss Healthcare Manufacturing Firm Lonza Bolsters Biologics Manufacturing Capacity With Roche's US Facility Acquisition For $1.2B
March 20, 2024
Lonza expands biologics manufacturing capacity with acquisition of Genentech facility in Vacaville, CA. $1.2 billion deal includes employee retention and facility upgrades. Transaction expected to...
Via
Benzinga
Galapagos Bets €225M On CellPoint Marking Its Entry Into CAR-T Field
June 22, 2022
Via
Benzinga
Should You Have Lonza Stock on Your Watchlist?
November 13, 2021
If it's stability you're looking for, probably so.
Via
The Motley Fool
Exposures
COVID-19
Moderna, Lonza Team Up To Produce New Drug Substance for COVID-19 Vaccine Doses
June 02, 2021
Moderna Inc (NASDAQ: MRNA) is gearing up to halve the dose of its COVID-19 vaccine so that it can also be used to combat variants and inoculate children. It has entered...
Via
Benzinga
Exposures
COVID-19
Moderna Tries To Boost COVID-19 Vaccine Supply Chain To Produce 3B Doses Annually
April 29, 2021
Moderna Inc (NASDAQ: MRNA) plans to produce up to 3 billion doses in 2022, doubling capacity at contract sites in Switzerland and Spain run by Lonza Group...
Via
Benzinga
Exposures
COVID-19
aTyr Pharma Recruits Lonza As Manufacturing Partner For Cancer Therapy ATYR2810
April 14, 2021
aTyr Pharma Inc (NASDAQ: LIFE) and Lonza Group Ltd (OTCMKTS: LZAGF) have agreed to manufacture ATYR2810, aTyr's monoclonal antibody targeting...
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.